Who Should Be Responsible for Relief of Financial Toxicity?
- PMID: 35271296
- DOI: 10.1200/OP.21.00885
Who Should Be Responsible for Relief of Financial Toxicity?
Conflict of interest statement
Comment in
-
Systems-Level Changes to Address Financial Toxicity in Cancer Care.JCO Oncol Pract. 2022 Apr;18(4):310-311. doi: 10.1200/OP.22.00085. Epub 2022 Mar 10. JCO Oncol Pract. 2022. PMID: 35271297 No abstract available.
Comment on
-
Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms.JCO Oncol Pract. 2022 Feb;18(2):140-147. doi: 10.1200/OP.21.00466. Epub 2021 Sep 24. JCO Oncol Pract. 2022. PMID: 34558297 Free PMC article. Review.
-
What Oncologists Must Account for: The Financial Burden of Cancer-Associated Symptom Relief.JCO Oncol Pract. 2022 Feb;18(2):106-108. doi: 10.1200/OP.21.00727. Epub 2021 Nov 30. JCO Oncol Pract. 2022. PMID: 34846913 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources